Agenus competitorsClear all

LogicBio Therapeutics's top competitors include Shanghai Henlius Biotech, Lava Therapeutics and Medivir.
LogicBio Therapeutics
LogicBio Therapeutics
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
Lava Therapeutics
Lava Therapeutics
Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.
Medivir
Medivir
Medivir researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.
Founding Date
Founding Date
2014
Founding Date
2009
Founding Date
2016
Founding Date
1988
Type
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
HQ
Locations
's-Hertogenbosch, NL HQ
Locations
Huddinge, SE HQ
Employees
Employees
23
Employees
1273% increase
Employees
4
Employees
738% decrease
Twitter followers
Twitter followers
308
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
200
Alexa Website Rank
Alexa Website Rank
172075
Alexa Website Rank
339329
Alexa Website Rank
179542
Alexa Website Rank
714123

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 156m (over 1 year ago)
Latest funding round
$ 18.7m (over 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 49m
Total funding raised
$ 346m
Total funding raised
$ 18.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Shanghai Henlius Biotech
HQ
Employees
127↑ 3% increase

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.

View company
Lava Therapeutics
HQ
's-Hertogenbosch, NL
Employees
4

Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.

View company
Medivir
HQ
Huddinge, SE
Employees
73↓ 8% decrease

Medivir researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.

View company